GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 236 filers reported holding GENMAB A/S in Q4 2022. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $382,926,894 | -16.1% | 15,237,839 | -0.1% | 0.13% | -16.8% |
| Q1 2024 | $456,257,519 | -8.2% | 15,254,347 | -2.3% | 0.16% | -15.7% |
| Q4 2023 | $497,165,998 | +48.1% | 15,614,510 | +64.1% | 0.19% | +33.6% |
| Q3 2023 | $335,601,421 | +7.8% | 9,515,209 | +16.2% | 0.14% | +12.6% |
| Q2 2023 | $311,209,764 | +21.8% | 8,187,576 | +21.0% | 0.13% | +16.5% |
| Q1 2023 | $255,509,119 | -4.8% | 6,766,661 | +6.8% | 0.11% | -9.9% |
| Q4 2022 | $268,503,491 | +44.6% | 6,335,618 | +9.6% | 0.12% | +34.4% |
| Q3 2022 | $185,695,000 | +3074.3% | 5,779,489 | +4217.3% | 0.09% | +4400.0% |
| Q3 2021 | $5,850,000 | +13.5% | 133,868 | +6.0% | 0.00% | 0.0% |
| Q2 2021 | $5,154,000 | -54.5% | 126,240 | -59.2% | 0.00% | -66.7% |
| Q3 2020 | $11,320,000 | +72.2% | 309,209 | +59.4% | 0.01% | +50.0% |
| Q2 2020 | $6,574,000 | – | 193,991 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 214,848 | $6,980,000 | 2.38% |
| Cutter & CO Brokerage, Inc. | 119,956 | $3,897,000 | 1.33% |
| Hardman Johnston Global Advisors LLC | 933,449 | $30,328,000 | 1.29% |
| Connective Portfolio Management, LLC | 18,000 | $585,000 | 1.00% |
| Capricorn Fund Managers Ltd | 148,411 | $4,822,000 | 0.88% |
| TORRAY INVESTMENT PARTNERS LLC | 131,708 | $4,279,000 | 0.82% |
| First Light Asset Management, LLC | 160,885 | $5,227,000 | 0.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,857 | $57,189,000 | 0.60% |
| Yorktown Management & Research Co Inc | 10,100 | $328,000 | 0.42% |
| Integrated Investment Consultants, LLC | 18,550 | $602,000 | 0.22% |